The emerging field of osteoimmunology
- 30 January 2009
- journal article
- review article
- Published by Springer Nature in Immunologic Research
- Vol. 45 (2-3) , 100-113
Abstract
Recent studies have elucidated unanticipated connections between the immune and skeletal systems, and this relationship has led to the development of a new field known as osteoimmunology. The goal of research in this field is to: (1) further understand how the bone microenvironment influences immune cell ontogeny and subsequent effector functions, and (2) translate basic science findings in bone biology to clinical applications for autoimmune diseases that target the skeleton such as rheumatoid arthritis (RA). In this review, we will examine the recent findings of the interplay between the immune and skeletal systems. This discussion will focus on the cells and signaling pathways in osteoimmune interactions and how innate and adaptive immune effector cells as well as cytokines and chemokines play a role in the maintenance and dysregulation of skeletal-immune homeostasis. We will also discuss how immunomodulatory biologic drugs, which specifically target these cells and effector molecules, have transformed the treatment of autoimmune mediated inflammatory diseases (IMIDs) and metabolic bone diseases such as osteoporosis.Keywords
This publication has 84 references indexed in Scilit:
- TH-17 cells in rheumatoid arthritisArthritis Research & Therapy, 2008
- The role of DC-STAMP in maintenance of immune tolerance through regulation of dendritic cell functionInternational Immunology, 2008
- The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγtNature Immunology, 2008
- The Biological Functions of T Helper 17 Cell Effector Cytokines in InflammationImmunity, 2008
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivoBlood, 2007
- Clinical development of anti-RANKL therapyArthritis Research & Therapy, 2007
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- Osteoclast differentiation and activationNature, 2003
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJournal of Clinical Investigation, 1999